Dealing with infectious disease

Issues hospitals should consider before handling an Ebola patient


When dealing with an infectious disease, the first issue a hospital has is treating the disease from a clinical standpoint. However, hospitals need to be concerned with the business aspect of treating patients with a high-profile infectious disease, according to an article on the Becker's Hospital Review website.

Experts say the first step to handling this type of situation from a business standpoint is to have a comprehensive response plan.

Infection control personnel and the CEO, director of nursing, CMO and communications director should be involved in the initial planning, the article said.

Among other things, the plan should look at:

• Communication

• Human resources and staffing

• HIPAA concerns

Read the article.

 

 



October 3, 2014


Topic Area: Safety


Recent Posts

Probiotic Cleaners: The Start of a Cleaning Revolution?

Advantages of probiotic cleaning include fewer resistant genes and cost savings through decreased antibiotic use.


Gun Incident Highlights Need for Security Infrastructure

A man was arrested at Aultman Memorial Hospital after allegedly firing a gun in the ER.


Creative Solutions in Healthcare Acquires 5 Skilled Nursing Facilities

Each location is planned to begin substantial upgrades to infrastructure and resident services.


Over 700 Hospitals at Risk of Closure

Hospitals are citing financial problems at the main cause of potential closure.


Astrana Health Fully Acquires Prospect Health

They completed the acquisition of Prospect Health for a total purchase price of $708 million.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.